Oct 31, 2024 6:30am EDT Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
Aug 14, 2024 4:05pm EDT Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
